Amoxycillin trihydrate equivqlent to amoxycillin, clavulanic acid
Sold as Myclav
(2R,3Z,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 5280980.
Background
Registration
- Applicants
- 1
- Registrations
- 2
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Unichem SA (Pty) Ltd | Myclav | 375, 625 | A390068, A390069 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Myclav 375 EACH TABLET CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVQLENT TO AMOXYCILLIN 250,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 125,0 mg | 375 | A390068A39/20.1.2/0068 | Registered | Not determined | None |
| Myclav 625 EACH TABLET CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVQLENT TO AMOXYCILLIN 500,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 125,0 mg | 625 | A390069A39/20.1.2/0069 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Amoxicillin
Consolidated Schedules 06 July 2026, line 5238
S4: Clavulanic acid
Consolidated Schedules 06 July 2026, line 5829
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.